TREGLY XR Trademark

Trademark Overview


On Monday, September 29, 2025, a trademark application was filed for TREGLY XR with the United States Patent and Trademark Office. The USPTO has given the TREGLY XR trademark a serial number of 99419747. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, June 1, 2026. The TREGLY XR trademark is filed in the Pharmaceutical Products category with the following description:

Anti-diabetic pharmaceuticals

General Information


Serial Number99419747
Word MarkTREGLY XR
Filing DateMonday, September 29, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, June 1, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2026

Trademark Statements


NOT AVAILABLE"XR"
Goods and ServicesAnti-diabetic pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 29, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressKapolei, HI 96707
US

Trademark Events


Event DateEvent Description
Monday, September 29, 2025NEW APPLICATION ENTERED
Monday, September 29, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 29, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, February 4, 2026ASSIGNED TO EXAMINER
Friday, February 6, 2026NON-FINAL ACTION WRITTEN
Friday, February 6, 2026NON-FINAL ACTION E-MAILED
Friday, February 6, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 30, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 30, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 30, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 23, 2026EXAMINERS AMENDMENT -WRITTEN
Saturday, May 23, 2026EXAMINERS AMENDMENT E-MAILED
Saturday, May 23, 2026EXAMINER'S AMENDMENT ENTERED
Saturday, May 23, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, May 23, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords


tregly pharmaceuticals diabetic anti